Court Refuses Life Tech's Request to Delay Countersuit as USPTO Reexamines Four Illumina Patents

The decision came after the USPTO granted Life Tech's request for an inter partes reexamination of the patents last month, and issued non-final office actions to reject all their claims as unpatentable.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.